Online Class Assignment

MHA FPX 5040 Assessment 1 Interview With a Healthcare Leader

MHA FPX 5040 Assessment 1 Interview With a Healthcare Leader

MHA FPX 5040 Assessment 1 Interview With a Healthcare Leader

Student Name

Capella University

MHA-FPX 5040 Health Administration Change Leadership

Prof. Name

Date

Interview with a Healthcare Leader

The hallmark of successful organizations is having prominent, driven leaders who are organized, proficient, and motivated for success. Such leaders can inspire team members, leadership staff, administrative leaders, and other stakeholders to progress and succeed collectively. Healthcare organizations, in particular, depend on exceptional leaders to uphold high standards individually, corporately, and in patient care. As healthcare continuously evolves, leaders in this field must be agile, flexible, and capable of adapting to rapid changes to maintain high-quality standards. Additionally, they must be adept at navigating political, socioeconomic, and environmental changes to meet regulatory and healthcare standards.

Interview with Arshad Khanani, MD: A Healthcare Leader at Sierra Eye Associates

Contact Information

NameAddressPhone Number
Arshad Khanani, MD, MA950 Ryland St., Reno, NV 89502(775) 329-0286

Organizational, Community, Political, Social, and Global Needs

With over 19 years in the medical field as a healthcare leader, ophthalmologist, and retina specialist, Dr. Arshad Khanani joined Sierra Eye Associates more than a decade ago and established the research department, making it one of the leading research clinics in the United States. Sierra Eye Associates is a private practice dedicated to patients with vision-threatening eye diseases, aiming to preserve and improve their vision. As a leader in clinical research, Dr. Khanani is involved in numerous clinical trials to develop new drugs and technologies for patients locally and globally.

The mission of Dr. Khanani and Sierra Eye Associates is to drive the latest innovations and provide cutting-edge treatments to patients. While Sierra Eye Associates operates as a local private ophthalmology practice, Dr. Khanani notes that there is no political influence affecting their primary focus on patient care and vision preservation. As a pioneer in clinical research and new technology, Dr. Khanani is driving change and innovation in ophthalmic drugs and devices that could have a global impact if approved and made available worldwide (Wong et al., 2023).

Community Wellness and Needs

Dr. Arshad Khanani is a vital part of the Northern Nevada ophthalmology community, leading in change and innovation. Serving thousands of patients monthly, he preserves their vision through referrals and consultations with primary care physicians, neurologists, optometrists, disease specialists, and other retina specialists. Dr. Khanani’s ability to accommodate emergency patients regularly, often providing treatment within 24 hours of consultation, has made his practice a trusted resource in the community (Khan et al., 2023).

MHA FPX 5040 Assessment 1 Interview With a Healthcare Leader

While many ophthalmology practices reject government-funded insurance patients such as Medicaid, Dr. Khanani’s practice accepts these patients, providing high-quality care to the underprivileged population. This inclusivity allows large families with Medicaid insurance to receive timely ophthalmic care, making a significant impact in the community through vision preservation and improvement (Khan et al., 2023).

Organizational Success Measurements

In the ophthalmology medicine sector, particularly in the vitreoretinal subspace, high-quality care is crucial for long-term success. Successful outcomes benefit the community and encourage patients with positive experiences to spread the word, bringing more patients to the practice. Referring physicians rely on Sierra Eye Associates for urgent ophthalmic care for patients with vision-threatening conditions. Dr. Khanani prides himself on maintaining and improving his patients’ vision daily, a key indicator of measured success (Wang et al., 2022).

Organizational and Specific Drivers of Change

Dr. Arshad Khanani prioritizes patients, ensuring that all are treated equally and ethically. As the Reno area grows, so does the healthcare burden. Currently the only retina specialist at Sierra Eye Associates, Dr. Khanani plans to hire more retina specialists to better serve the growing community. This expansion is driven by the increasing population and the need to provide more patients with timely care, ensuring the practice continues to prioritize patient care and vision preservation.

Effectiveness and Evaluation of Traditional Leadership Models

The fast-paced healthcare industry requires agile, flexible leaders who can guide organizations through change management. Change management models provide guidelines for planning and implementing effective change. At Sierra Eye Associates, Lewin’s change management model is used to implement and solidify changes. This model consists of three steps: unfreeze, change, and refreeze. During the unfreeze stage, the organization is prepared for change through communication. In the change stage, changes are implemented. The refreeze stage involves checking in with staff to ensure the changes are effective and properly implemented (Phillips & Klein, 2023).

References

Khan, H., Aziz, A. A., Sulahria, H., Ahmed, A., Choudhry, N., Narayanan, R., Danzig, C., & Khanani, A. M. (2023). Emerging Treatment Options for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration. Clinical Ophthalmology, 17, 321-327. https://doi.org/10.2147/OPTH.S367089

Phillips, J., & Klein, J. D. (2023). Change Management: From Theory to Practice. TechTrends, 67(1), 189-197. https://doi.org/10.1007/s11528-022-00775-0

MHA FPX 5040 Assessment 1 Interview With a Healthcare Leader

Wang, R., McClard, C. K., Laswell, S., Mahmoudzadeh, R., Salabati, M., Ammar, M., Vannavong, J., Aziz, A. A., Ewald, A., Calvanese, A. V., Lehman, E. B., Fried, S., Windham, V., Strutt, A., Saroj, N., Arshad, M. K., Eichenbaum, D. A., Regillo, C., & Charles, C. W. (2022). Quantifying burden of intravitreal injections for retinal diseases in the United States: Insights from a multicenter chart review. Retina, 42(8), 1495-1503. https://doi.org/10.1097/IAE.0000000000003143